RAPT Therapeutics, Inc. (RAPT)

RAPT Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	41.89	169.74	47.48	38.95	24.03	24.92
Short-Term Investments	127.06	61.32	111.38	210.12	165.63	86.59
Cash & Short-Term Investments	168.95	231.06	158.86	249.07	189.65	111.51
Cash Growth	47.12%	45.44%	-36.22%	31.33%	70.08%	44.10%
Prepaid Expenses	3.91	4.18	2.92	3.63	3.32	4.09
Total Current Assets	172.86	235.24	161.78	252.69	192.97	115.6
Property, Plant & Equipment	3.28	4.7	7.68	9.48	2.74	2.98
Other Long-Term Assets	2.27	0.39	3.87	4.04	2.92	0.39
Total Assets	178.41	240.33	173.33	266.21	198.64	118.97
Accounts Payable	4.19	1.28	5.18	3.37	2	2.38
Accrued Expenses	6.58	44.6	14.1	8.66	6.33	4.94
Current Portion of Leases	2.21	2.42	2.45	2.17	-	-
Current Unearned Revenue	-	-	-	-	1.02	4.1
Other Current Liabilities	0.07	0.06	0.11	0.03	0.25	0.33
Total Current Liabilities	13.04	48.35	21.84	14.22	9.6	11.74
Long-Term Leases	0.96	2.07	4.46	6.82	-	-
Long-Term Unearned Revenue	-	-	-	-	0.51	0.86
Other Long-Term Liabilities	-	-	-	-	2.15	2.19
Total Liabilities	14	50.42	26.29	21.04	12.26	14.79
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	813.73	804.39	631.61	613.07	470.63	319.2
Retained Earnings	-649.36	-614.55	-484.68	-367.88	-284.05	-214.84
Comprehensive Income & Other	0.02	0.05	0.1	-0.03	-0.21	-0.18
Total Common Equity	164.41	189.9	147.04	245.17	186.38	104.18
Shareholders' Equity	164.41	189.9	147.04	245.17	186.38	104.18
Total Liabilities & Equity	178.41	240.33	173.33	266.21	198.64	118.97
Total Debt	3.16	4.49	6.91	8.99	-	-
Net Cash (Debt)	165.78	226.56	151.96	240.08	189.65	111.51
Net Cash Growth	51.94%	49.10%	-36.71%	26.59%	70.08%	44.10%
Net Cash Per Share	10.27	44.47	31.71	59.02	55.39	36.96
Filing Date Shares Outstanding	16.54	16.5	4.35	4.29	3.7	3.11
Total Common Shares Outstanding	16.54	16.5	4.3	4.28	3.69	3.1
Working Capital	159.82	186.89	139.95	238.47	183.38	103.86
Book Value Per Share	9.94	11.51	34.20	57.26	50.45	33.64
Tangible Book Value	164.41	189.9	147.04	245.17	186.38	104.18
Tangible Book Value Per Share	9.94	11.51	34.20	57.26	50.45	33.64
Machinery	8.18	8.15	8.52	7.49	7.13	6.77
Leasehold Improvements	3.3	3.3	3.3	3.3	3.3	3.29

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q